Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Khan, Asma A
NCT06053983: Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome	Completed	4	126	RoW	Turbox CRP kit, rosuvastatin 20 mg,, atorvastatin 40 mg	Rawalpindi Medical College	Mi Q Wave	08/23	08/23
NCT05310734: PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies	Recruiting	4	50	US	Spinosad Topical, Natroba, benzyl alcohol	ParaPRO LLC, Concentrics Research, Iqvia Pty Ltd, Medpace, Inc., Inotiv Laboratories, BioAgilytix	Scabies	11/25	03/26